Major Depressive Disorder — A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms
Citation(s)
A Phase 4, 8-Week, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of Duloxetine 60 mg Once Daily in Outpatients With Major Depressive Disorder and Associated Painful Physical Symptoms